Literature DB >> 25710566

Aromatase inhibitors for ovulation induction.

Stefano Palomba1.   

Abstract

Normogonadotropic anovulation, including polycystic ovary syndrome (PCOS), is one of the main causes of infertility. Recent meta-analysis and randomized controlled trial suggest the use of aromatase inhibitors (ie, letrozole) as effective drug and first-line treatment to restore fertility in these patients. The current manuscript will give a critical, provocative, and personal point of view on the topic.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25710566     DOI: 10.1210/jc.2014-4235

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

Review 2.  Contemporary approaches to the management of polycystic ovary syndrome.

Authors:  Renato Pasquali
Journal:  Ther Adv Endocrinol Metab       Date:  2018-02-07       Impact factor: 3.565

Review 3.  Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Alexandra P Tsiami; Dimitrios G Goulis; Alexandros I Sotiriadis; Efstratios M Kolibianakis
Journal:  Hormones (Athens)       Date:  2021-05-25       Impact factor: 2.885

4.  Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study.

Authors:  Xiaoyi Yang; Ge Lin; Guangxiu Lu; Fei Gong
Journal:  Reprod Biol Endocrinol       Date:  2019-05-10       Impact factor: 5.211

Review 5.  Letrozole for Female Infertility.

Authors:  Ai-Min Yang; Na Cui; Yi-Fei Sun; Gui-Min Hao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

Review 6.  Complications and challenges associated with polycystic ovary syndrome: current perspectives.

Authors:  Stefano Palomba; Susanna Santagni; Angela Falbo; Giovanni Battista La Sala
Journal:  Int J Womens Health       Date:  2015-07-31

Review 7.  Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?

Authors:  Stefano Palomba; Susanna Santagni; Giovanni Battista La Sala
Journal:  J Ovarian Res       Date:  2015-11-19       Impact factor: 4.234

8.  Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

Authors:  Jigal Haas; Rawad Bassil; Jim Meriano; Nivin Samara; Eran Barzilay; Noa Gonen; Robert F Casper
Journal:  Reprod Biol Endocrinol       Date:  2017-08-30       Impact factor: 5.211

Review 9.  Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome.

Authors:  Ahmad J H Albaghdadi; Frederick W K Kan
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

Review 10.  Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis

Authors:  Rui Wang; Bobae V Kim; Madelon van Wely; Neil P Johnson; Michael F Costello; Hanwang Zhang; Ernest Hung Yu Ng; Richard S Legro; Siladitya Bhattacharya; Robert J Norman; Ben Willem J Mol
Journal:  BMJ       Date:  2017-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.